drugset / Trial / NCT03193593
Study to Evaluate EB-001 in Reducing Musculoskeletal Pain
RandomizedSequentialQuadruple-blindTreatment
Summary
To determine the safety and efficacy of single intra-operative treatment of EB-001 IM injections into the Pectoralis Major (PM) in subjects undergoing breast augmentation with subpectoral implants
Timeline
- Start
- 2017-08-29
- Primary completion
- 2018-04-26
- Completion
- 2018-08-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | EB-001 | Protein / enzyme biologic | — | Intramuscular |